- Home
- INZY vs TDUP Comparison
INZY vs TDUP Comparison
Compare INZY & TDUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- TDUP
- Stock Information
- Founded
- INZY 2015
- TDUP 2009
- Country
- INZY United States
- TDUP United States
- Employees
- INZY N/A
- TDUP N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- TDUP Catalog/Specialty Distribution
- Sector
- INZY Health Care
- TDUP Consumer Discretionary
- Exchange
- INZY Nasdaq
- TDUP Nasdaq
- Market Cap
- INZY 188.2M
- TDUP 172.9M
- IPO Year
- INZY 2020
- TDUP 2021
- Fundamental
- Price
- INZY $1.66
- TDUP $1.27
- Analyst Decision
- INZY Strong Buy
- TDUP Buy
- Analyst Count
- INZY 7
- TDUP 5
- Target Price
- INZY $16.43
- TDUP $3.50
- AVG Volume (30 Days)
- INZY 666.9K
- TDUP 426.6K
- Earning Date
- INZY 11-05-2024
- TDUP 03-03-2025
- Dividend Yield
- INZY N/A
- TDUP N/A
- EPS Growth
- INZY N/A
- TDUP N/A
- EPS
- INZY N/A
- TDUP N/A
- Revenue
- INZY N/A
- TDUP $313,757,000.00
- Revenue This Year
- INZY N/A
- TDUP N/A
- Revenue Next Year
- INZY N/A
- TDUP N/A
- P/E Ratio
- INZY N/A
- TDUP N/A
- Revenue Growth
- INZY N/A
- TDUP 0.58
- 52 Week Low
- INZY $1.97
- TDUP $0.50
- 52 Week High
- INZY $7.80
- TDUP $2.42
- Technical
- Relative Strength Index (RSI)
- INZY 24.23
- TDUP 40.56
- Support Level
- INZY $2.68
- TDUP $1.30
- Resistance Level
- INZY $3.18
- TDUP $1.59
- Average True Range (ATR)
- INZY 0.27
- TDUP 0.11
- MACD
- INZY -0.08
- TDUP -0.04
- Stochastic Oscillator
- INZY 0.35
- TDUP 7.89
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.
About TDUP ThredUp Inc.
ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners. Geographically, the majority of the company's revenue is generated from United States.